-transparent.png){kind=logo}
Four cases of tumorous endobronchial tuberculosis (EBTB) were prospectively evaluated to assess the effect of antitubercular treatment (ATT) on tumorous EBTB. All 4 patients received standard ATT (isoniazid, rifampicin, ethambutol, and pyrizinamide for 2 months followed by isoniazid and rifampicin). At the completion of ATT, bronchoscopy was repeated in all cases and no residual structural abnormality of the bronchus was identified. Short-course ATT without corticosteroid is effective in preventing residual endobronchial complication of tumorous EBTB.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Sajal De
January 2007,
The Indian journal of chest diseases & allied sciences,
Sajal De
January 1975,
Problemy tuberkuleza,
Sajal De
January 1969,
Vrachebnoe delo,
Sajal De
June 2013,
The Journal of thoracic and cardiovascular surgery,
Sajal De
January 1966,
Problemy tuberkuleza,
Sajal De
February 1948,
Journal of the Indian Medical Association,
Sajal De
January 2016,
Journal of human reproductive sciences,
Sajal De
January 1997,
Scandinavian cardiovascular journal : SCJ,
Sajal De
April 1975,
Gruzlica i choroby pluc; tuberculosis et pneumonologia,
Sajal De
February 2019,
Frontiers of medicine,
